ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Bicara Therapeutics Inc

Bicara Therapeutics Inc (BCAX)

11.605
-0.32
(-2.64%)
Closed January 24 4:00PM
11.4299
-0.1751
( -1.51% )
Pre Market: 8:00AM

Bicara Therapeutics Inc Financial Summary

The current BCAX market cap is 621.97M. The company's latest EPS is USD -0.9553 and P/E is -12.14.

Quarter End Sep 2024
USD ($)
Total Revenue 0
Operating Income -20.63M
Net Income -17.48M
Year End December 30 2023 2023
USD ($)
Total Revenue 0
Operating Income -39.89M
Net Income -51.99M
Quarter End Sep 2024
USD ($)
Total Assets 524.17M
Total Liabilities 14.62M
Total Equity 509.56M
Year End December 30 2023 2023
USD ($)
Total Assets 233.98M
Total Liabilities 15.47M
Total Equity -148.77M
Quarter End Sep 2024
USD ($)
Operating -44.72M
Investing 31k
Financing 335.01M
Year End December 30 2023 2023
USD ($)
Operating -45.63M
Investing -586k
Financing 272.5M
Market Cap 621.97M
Price to Earnings Ratio -12.14
Price to Sales Ratio 0
Price to Cash Ratio 2.74
Price to Book Ratio 2.89
Dividend Yield -

Share Statistics

Shares Outstanding 54.42M
Average Volume (1 week) 315.76k
Average Volume (1 Month) 365.76k
52 Week Change -56.46%
52 Week High 27.95
52 Week Low 11.42
Spread (Intraday) 5.57 (32.76%)

Company Info

Company Name Bicara Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.bicara.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock